SCHEMBL9908099

SCHEMBL9908099

CC(C)CC(C(=O)Nc1cnccn1)N1C(=O)Cc2cc(Br)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
THRB P10828 1/20 0.38
FFAR2 O15552 1/20 0.37
GCK P35557 4/20 0.37
LRRK2 Q5S007 1/20 0.37
RAB9A P51151 4/20 0.35
NPC1 O15118 2/20 0.35
KMT2A Q03164 1/20 0.35
BMPR1B O00238 1/20 0.35
BMPR1A P36894 1/20 0.35
TGFBR1 P36897 1/20 0.35
ACVRL1 P37023 1/20 0.35
ACVR1 Q04771 1/20 0.35
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
FPR2 P25090 1/20 0.34
PSMB5 P28074 1/20 0.34
FNTA P49354 1/20 0.34
FNTB P49356 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9103176 1.00 GAA (0.38) GAATHRBFFAR2GCKLRRK2
SCHEMBL9908105 0.90 RAB9A (0.43) GAATHRBFFAR2GCKRAB9A
SCHEMBL9108970 0.90 RAB9A (0.43) GAATHRBFFAR2GCKRAB9A
SCHEMBL9106629 0.89 FFAR2 (0.46) GAATHRBFFAR2GCKRAB9A
SCHEMBL9908112 0.89 FFAR2 (0.46) GAATHRBFFAR2GCKRAB9A
SCHEMBL9101981 0.88 KDM4E (0.43) GAATHRBFFAR2GCKRAB9A
SCHEMBL9908093 0.88 KDM4E (0.43) GAATHRBFFAR2GCKRAB9A
SCHEMBL9107559 0.88 RAB9A (0.41) GCKRAB9ANPC1KDM4EPOLB
SCHEMBL9107744 0.85 GCK (0.52) GCKFPR2KCNH2
SCHEMBL9908095 0.85 GCK (0.52) GCKFPR2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT GAA 1195/4885THRB 2997/4885FFAR2 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.